Michael D. Hughes

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile

0.853Author DataRank

Indexed papers

4in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 4 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Association Between Anterior Nasal and Plasma SARS-CoV-2 RNA Levels and Hospitalization or Death in Nonhospitalized Adults With Mild-to-Moderate COVID-19

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad287

Top 29%

0.688DataRank

Top 29%7 citations

Kara W Chew, Joseph J. Eron, Jonathan Z. Li, Mauricio Pinilla, Carlee Moser +32 more

Papers

Driven by 86 papers — median percentile 30. Top paper: “Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection”.

Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection

Annals of Internal Medicine(2023)10.7326/m22-2381

N/A

2.0DataRank · unranked

63 citations

Manish C. Choudhary, Carlee Moser, Justin Ritz, Eric S. Daar, David A. Wohl +41 more

Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial

Nature Microbiology(2022)10.1038/s41564-022-01254-1

N/A

1.6DataRank · unranked

53 citations

Kara W Chew, Rinki Deo, James P. Flynn, James Regan, Charles R. Crain +51 more

Comparative Pharmacokinetics of Tixagevimab/Cilgavimab (AZD7442) Administered Intravenously Versus Intramuscularly in Symptomatic SARS‐CoV‐2 Infection

Clinical Pharmacology & Therapeutics(2022)10.1002/cpt.2706

N/A

1.2DataRank · unranked

14 citations

David A. Wohl, Rosalin Arends, Venkatesh Pilla Reddy, Ying Mu, Arzhang Cyrus Javan +8 more

Safety and Efficacy of Starting Antiretroviral Therapy in the First Week of Life

Clinical Infectious Diseases(2020)10.1093/cid/ciaa028

N/A

1.0DataRank · unranked

28 citations

Gbolahan Ajibola, Kara Bennett, Edmund V. Capparelli, Patrick Jean‐Philippe, Sikhulile Moyo +10 more

Immune correlates of HIV-1 reservoir cell decline in early-treated infants

Cell Reports(2022)10.1016/j.celrep.2022.111126

N/A

0.953DataRank · unranked

40 citations

Pilar García‐Broncano, Yelizaveta Rassadkina, Xiaodong Lian, Chenyang Jiang, Kevin Einkauf +21 more

Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19

Annals of Internal Medicine(2023)10.7326/m22-3428

N/A

0.785DataRank · unranked

31 citations

Kara W Chew, Mark J Giganti, Carlee Moser, Mauricio Pinilla, David A. Wohl +76 more

Resistance toMycobacterium tuberculosisInfection Among Household Contacts: A Multinational Study

Clinical Infectious Diseases(2021)10.1093/cid/ciab269

N/A

0.736DataRank · unranked

15 citations

Neel R. Gandhi, Soyeon Kim, Michael D. Hughes, Vidya Mave, Alberto Mendoza‐Ticona +13 more

Association Between Anterior Nasal and Plasma SARS-CoV-2 RNA Levels and Hospitalization or Death in Nonhospitalized Adults With Mild-to-Moderate COVID-19

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad287

Top 29%

0.688DataRank

Top 29%7 citations

Kara W Chew, Joseph J. Eron, Jonathan Z. Li, Mauricio Pinilla, Carlee Moser +32 more

Bamlanivimab reduces nasopharyngeal SARS-CoV-2 RNA levels but not symptom duration in non-hospitalized adults with COVID-19

medRxiv(2021)10.1101/2021.12.17.21268009

N/A

0.626DataRank · unranked

14 citations

Carlee Moser, Eric S. Daar, David A. Wohl, Jonathan Z. Li, Robert W. Coombs +18 more

One Week of Oral Camostat Versus Placebo in Nonhospitalized Adults With Mild-to-Moderate Coronavirus Disease 2019: A Randomized Controlled Phase 2 Trial

Clinical Infectious Diseases(2023)10.1093/cid/ciad342

N/A

0.622DataRank · unranked

19 citations

Kara W Chew, Mark J Giganti, Eric S. Daar, David A. Wohl, Arzhang Cyrus Javan +47 more

Prebiotic Inulin Supplementation and Peripheral Insulin Sensitivity in adults at Elevated Risk for Type 2 Diabetes: A Pilot Randomized Controlled Trial

Nutrients(2021)10.3390/nu13093235

N/A

0.614DataRank · unranked

59 citations

Brenda M. Davy, Monica A. Ponder, Ryan P. McMillan, Michael D. Hughes, Matthew W. Hulver +3 more

Bamlanivimab therapy for acute COVID-19 does not blunt SARS-CoV-2–specific memory T cell responses

JCI Insight(2022)10.1172/jci.insight.163471

N/A

0.587DataRank · unranked

13 citations

Alba Grifoni, Daniela Weiskopf, Urvi M. Parikh, Amy Heaps, Farhoud Faraji +15 more

Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trial

EClinicalMedicine(2023)10.1016/j.eclinm.2023.102250

N/A

0.587DataRank · unranked

12 citations

Kara W Chew, Mark J Giganti, Michael D. Hughes, Carlee Moser, Mark Main +79 more

Nasal and Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Levels Are Associated With Timing of Symptom Resolution in the ACTIV-2 Trial of Nonhospitalized Adults With Coronavirus Disease 2019

Clinical Infectious Diseases(2022)10.1093/cid/ciac818

N/A

0.583DataRank · unranked

10 citations

Linda J Harrison, Kara W Chew, Judy Currier, David A. Wohl, Eric S. Daar +12 more

Immune Status and SARS-CoV-2 Viral Dynamics

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad200

N/A

0.550DataRank · unranked

13 citations

Carlee Moser, Evgenia Aga, Judith S. Currier, David A. Wohl, Eric S. Daar +30 more

Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody

PLoS Pathogens(2024)10.1371/journal.ppat.1011680

N/A

0.541DataRank · unranked

17 citations

Carolin Zitzmann, Kara W Chew, Davey M. Smith, Eric S. Daar, David A. Wohl +11 more

Early antiviral CD4+ and CD8+ T cells are associated with upper airway clearance of SARS-CoV-2

JCI Insight(2024)10.1172/jci.insight.186078

N/A

0.540DataRank · unranked

13 citations

Paul Lopez, Farhoud Faraji, Urvi M. Parikh, Amy Heaps, Justin Ritz +17 more

Phase 2 Safety and Antiviral Activity of SAB-185, a Novel Polyclonal Antibody Therapy for Nonhospitalized Adults With COVID-19

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad013

N/A

0.496DataRank · unranked

12 citations

Kara W Chew, Carlee Moser, David A. Wohl, Eric S. Daar, Jonathan Z. Li +42 more

Safety and Efficacy of Combined Tixagevimab and Cilgavimab Administered Intramuscularly or Intravenously in Nonhospitalized Patients With COVID-19

JAMA Network Open(2023)10.1001/jamanetworkopen.2023.10039

N/A

0.490DataRank · unranked

11 citations

Kara W Chew, Carlee Moser, Judith S. Currier, Joseph J. Eron, Arzhang Cyrus Javan +47 more

Statistical issues for HIV surrogate endpoints: point/counterpoint

Statistics in Medicine(1998)10.1002/(sici)1097-0258(19981115)17:21<2435::aid-sim994>3.3.co;2-7

N/A

0.483DataRank · unranked

24 citations

Patricia Reichelderfer, Brian Conway, Robert W. Coombs, Lawrence Crane, Ralph Demasi +21 more

Statistical Challenges When Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical Trials

(2023)10.1093/infdis/jiad285

N/A

0.475DataRank · unranked

7 citations

Kara W Chew, Mark J Giganti, Jonathan Z. Li, Evgenia Aga, Justin Ritz +24 more

ACTIV-2: A Platform Trial for the Evaluation of Novel Therapeutics for the Treatment of Early COVID-19 in Outpatients

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad246

N/A

0.463DataRank · unranked

15 citations

Carlee Moser, Joseph J. Eron, Kara W Chew, Davey M. Smith, Arzhang Cyrus Javan +13 more

Variant-Specific Viral Kinetics in Acute COVID-19

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad314

N/A

0.395DataRank · unranked

5 citations

Manish C. Choudhary, Rinki Deo, Mark J Giganti, Carlee Moser, Justin Ritz +26 more

Drug susceptibility patterns of Mycobacterium tuberculosis from adults with multidrug-resistant tuberculosis and implications for a household contact preventive therapy trial

BMC Infectious Diseases(2021)10.1186/s12879-021-05884-4

N/A

0.373DataRank · unranked

11 citations

Anne‐Marie Demers, Soyeon Kim, Sara McCallum, Kathleen D. Eisenach, Michael D. Hughes +14 more

Adverse Pregnancy Outcomes Among Women with Human Immunodeficiency Virus Taking Isoniazid Preventive Therapy During the First Trimester

Clinical Infectious Diseases(2023)10.1093/cid/ciad583

N/A

0.360DataRank · unranked

10 citations

Michael D. Hughes, Jorge Leon Cruz, Anchalee Avihingsanon, Noluthando Mwelase, Patrice Sévère +7 more

Pooling Different Placebos as a Control Group in a Randomized Platform Trial: Benefits and Challenges From Experience in the ACTIV-2 COVID-19 Trial

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad209

N/A

0.344DataRank · unranked

8 citations

Kara W Chew, Justin Ritz, Matthew Newell, Arzhang Cyrus Javan, Joseph J. Eron +19 more

1-Year Incidence of Tuberculosis Infection and Disease Among Household Contacts of Rifampin- and Multidrug-Resistant Tuberculosis

Clinical Infectious Diseases(2023)10.1093/cid/ciad301

N/A

0.312DataRank · unranked

7 citations

Xingye Wu, Soyeon Kim, Katie McIntire, Linda Naini, Michael D. Hughes +21 more

Validity and Characterization of Time to Symptom Resolution Outcome Measures in the ACTIV-2/A5401 Outpatient COVID-19 Treatment Trial

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad300

N/A

0.270DataRank · unranked

3 citations

Carlee Moser, Eunice Yeh, David A. Wohl, Eric S. Daar, Justin Ritz +7 more

Long COVID After Bamlanivimab Treatment

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad286

N/A

0.251DataRank · unranked

4 citations

Carlee Moser, Nikolaus Jilg, Eunice Yeh, Busola Sanusi, David A. Wohl +32 more

Effectiveness of Double-Dose Dolutegravir in People Receiving Rifampin-based Tuberculosis Treatment: An Observational, Cohort Study of People With HIV From 6 Countries

Clinical Infectious Diseases(2024)10.1093/cid/ciae269

N/A

0.241DataRank · unranked

4 citations

Cissy Kityo, Michael D. Hughes, Caitlyn McCarthy, Carole L. Wallis, Mina C. Hosseinipour +28 more

Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial

EClinicalMedicine(2024)10.1016/j.eclinm.2024.102787

N/A

0.208DataRank · unranked

3 citations

Carlee Moser, Nikolaus Jilg, Justin Ritz, David A. Wohl, Jonathan Z. Li +89 more

Long-Term Clinical, Immunologic, and Viral Reservoir Outcomes in Children Treated With VRC01LS and 10-1074 Monoclonal Antibodies in the Tatelo Study

Clinical Infectious Diseases(2025)10.1093/cid/ciaf568

N/A

0.208DataRank · unranked

3 citations

Bryan S Nelson, Aischa Niesar, Seohyun Hong, Mélanie Lancien, Molly Pretorius-Holme +14 more

SARS-CoV-2 Plasma Antibody and Nucleocapsid Antigen Status Predict Outcomes in Outpatients With COVID-19

Clinical Infectious Diseases(2024)10.1093/cid/ciae324

N/A

0.189DataRank · unranked

2 citations

Mark J Giganti, Kara W Chew, Kathryn Shaw‐Saliba, Justin Ritz, Carlee Moser +10 more

Safety and Efficacy of SAB-185 for Nonhospitalized Adults With COVID-19: A Randomized Clinical Trial

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae369

N/A

0.165DataRank · unranked

2 citations

Babafemi Taiwo, Carlee Moser, Eric S. Daar, David A. Wohl, Justin Ritz +46 more

Incidence and Predictors of Pregnancy in Women Enrolled in Large Multinational HIV Treatment Trials of the AIDS Clinical Trials Group

JAIDS Journal of Acquired Immune Deficiency Syndromes(2023)10.1097/qai.0000000000003299

Top 70%

0.165DataRank

Top 70%2 citations

Michael D. Hughes, Bao Yajing, William R. Short, Rosie Mngqibisa, Susan E. Cohn +7 more

Factors associated with prevalent Mycobacterium tuberculosis infection and disease among adolescents and adults exposed to rifampin-resistant tuberculosis in the household

PLoS ONE(2023)10.1371/journal.pone.0283290

N/A

0.165DataRank · unranked

2 citations

Anneke C. Hesseling, Xingye Wu, Michael D. Hughes, N. Sarita Shah, Sanjay Gaikwad +22 more

The statistical design and analysis of pandemic platform trials: Implications for the future

Journal of Clinical and Translational Science(2024)10.1017/cts.2024.514

N/A

0.165DataRank · unranked

2 citations

Matthew Shotwell, Kevin J. Anstrom, Scott Berry, Erica Brittain, Frank E. Harrell +13 more

Tixagevimab/cilgavimab or placebo for COVID-19 in ACTIV-2: Safety, pharmacokinetics and neutralizing and anti-drug antibodies

iScience(2025)10.1016/j.isci.2025.111938

N/A

0.104DataRank · unranked

1 citations

Kara W Chew, Carlee Moser, Judith S. Currier, Joseph J. Eron, Arzhang Cyrus Javan +14 more

Decreased diarrheal and respiratory disease in HIV exposed uninfected children following vaccination with rotavirus and pneumococcal conjugate vaccines

PLoS ONE(2020)10.1371/journal.pone.0244100

N/A

0DataRank · unranked

3 citations

Kara Bennett, Kathleen M. Powis, Michael D. Hughes, Jean Leidner, Samuel W. Kgole +6 more

Antiretroviral Therapy and Efficacy After Virologic Failure on First-line Boosted Protease Inhibitor Regimens

UNC Libraries(2020)10.17615/edhz-rv55

N/A

0DataRank · unranked

0 citations

Yu Zheng, Robert A. Salata, Mina C. Hosseinipour, Eric S. Daar, Michael D. Hughes +8 more

Bamlanivimab therapy for acute COVID-19 does not blunt SARS-CoV-2-specific memory T cell responses

UNC Libraries(2022)10.17615/473v-1p84

N/A

0DataRank · unranked

0 citations

Urvi M. Parikh, Judith S. Currier, Shane Crotty, Carlee Moser, Alessandro Sette +14 more

Protecting households on exposure to newly diagnosed index multidrug-resistant tuberculosis patients: Study protocol for the PHOENIx phase 3 clinical trial

Contemporary Clinical Trials(2025)10.1016/j.cct.2025.108084

N/A

0DataRank · unranked

0 citations

Michael D. Hughes, Soyeon Kim, Lisa Aaron, Linda Naini, Nishi Suryavanshi +14 more

Predictors of virologic outcome among people living with HIV who continue a protease inhibitor-based antiretroviral regimen following virologic failure with no or limited resistance

AIDS Research and Therapy(2023)10.1186/s12981-022-00494-9

N/A

0DataRank · unranked

1 citations

Beatriz Grinsztejn, Justin Ritz, Ann C. Collier, Evelyn Hogg, Robert Gross +8 more

Qualitative interviews to evaluate content validity of the ACTIV-2 COVID-19 Symptom Diary (ACSD)

Journal of Patient-Reported Outcomes(2023)10.1186/s41687-022-00535-x

N/A

0DataRank · unranked

3 citations

Katie D. Stewart, April N. Naegeli, Kayla M Mills, Karin S. Coyne, Kara W Chew +3 more

Viral and Symptom Rebound in Untreated COVID-19 Infection

medRxiv(2022)10.1101/2022.08.01.22278278

N/A

0DataRank · unranked

21 citations

Manish C. Choudhary, Carlee Moser, Justin Ritz, Eric S. Daar, David A. Wohl +9 more

Safety and Efficacy of SAB-185 for Non-hospitalized Adults with COVID-19: A Randomized Clinical Trial

UNC Libraries(2025)10.17615/h4dx-ze98

N/A

0DataRank · unranked

0 citations

Luke, Thomas, David A. Wohl, Alexander L. Greninger, Christoph Bausch, Davey M. Smith +16 more

Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.09.14.557679

N/A

0DataRank · unranked

5 citations

Carolin Zitzmann, Kara W Chew, Davey M. Smith, Eric S. Daar, David A. Wohl +11 more

Early antiviral CD4 and CD8 T cell responses and antibodies are associated with upper respiratory tract clearance of SARS-CoV-2

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.10.25.564014

N/A

0DataRank · unranked

3 citations

Paul Lopez, Farhoud Faraji, Urvi M. Parikh, Amy Heaps, Justin Ritz +17 more

Statistical Challenges when Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical Trials

medRxiv(2023)10.1101/2023.03.13.23287208

N/A

0DataRank · unranked

2 citations

Kara W Chew, Mark J Giganti, Jonathan Z. Li, Evgenia Aga, Justin Ritz +10 more

Predictors of SARS-CoV-2 RNA From Nasopharyngeal Swabs and Concordance With Other Compartments in Nonhospitalized Adults With Mild to Moderate COVID-19

UNC Libraries(2023)10.17615/vptt-dg28

N/A

0DataRank · unranked

0 citations

Arzhang Cyrus Javan, Joseph J. Eron, Justin Ritz, Judith S. Currier, Prasanna Jagannathan +12 more

Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial

UNC Libraries(2023)10.17615/s90c-rs31

N/A

0DataRank · unranked

0 citations

Jonathan Z. Li, Paul Klekotka, James P. Flynn, Joseph J. Eron, Justin Ritz +23 more

Nasal and Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Levels Are Associated With Timing of Symptom Resolution in the ACTIV-2 Trial of Nonhospitalized Adults With Coronavirus Disease 2019

UNC Libraries(2023)10.17615/x7r0-1v04

N/A

0DataRank · unranked

0 citations

Joseph J. Eron, Kara W Chew, Michael D. Hughes, Carlee Moser, Judy Currier +12 more

Nasal and Plasma SARS-CoV-2 RNA Levels are Associated with Timing of Symptom Resolution in the ACTIV-2 Trial of Non-hospitalized Adults with COVID-19

UNC Libraries(2023)10.17615/ra63-p116

N/A

0DataRank · unranked

0 citations

Jonathan Z. Li, Carlee Moser, Arzhang Cyrus Javan, Judy Currier, Michael D. Hughes +12 more

Hyperlipidaemia in HIV-infected patients on lopinavir/ritonavir monotherapy in resource-limited settings

UNC Libraries(2020)10.17615/5gvq-zc89

N/A

0DataRank · unranked

4 citations

Nagalingeswaran Kumarasamy, Mina C. Hosseinipour, John Bartlett, Evgenia Aga, Mitch Matoga +2 more

SARS-CoV-2 Monoclonal Antibody Treatment Followed by Vaccination Shifts Human Memory B-Cell Epitope Recognition, Suggesting Antibody Feedback

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae371

N/A

0DataRank · unranked

13 citations

Sydney I. Ramirez, Hallie Cohn, Urvi M. Parikh, Amy Heaps, Scott F. Sieg +22 more

96 Evaluation of predictors and impact of losses to follow-up in the domain of hiv infection

Controlled Clinical Trials(1997)10.1016/s0197-2456(97)91081-3

N/A

0DataRank · unranked

0 citations

Roland Bassett, Michael D. Hughes, Paul A. Volberding, Henry S. Sacks, Joseph Lau +2 more

Discontinuation of tenofovir disoproxil fumarate from initial ART regimens because of renal adverse events: An analysis of data from four multi-country clinical trials

PLOS Global Public Health(2024)10.1371/journal.pgph.0002648

N/A

0DataRank · unranked

8 citations

Justin Ritz, Michael D. Hughes, Mitch Matoga, Mina C. Hosseinipour, McNeil Ngongondo

Characterization of Treatment Resistance and Viral Kinetics in the Setting of Single-Active Versus Dual-Active Monoclonal Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae192

N/A

0DataRank · unranked

7 citations

Rinki Deo, Teresa H. Evering, Kara W Chew, Mark J Giganti, Carlee Moser +17 more

Emergence of SARS-CoV-2 Resistance with Monoclonal Antibody Therapy

medRxiv(2021)10.1101/2021.09.03.21263105

N/A

0DataRank · unranked

21 citations

Kara W Chew, Rinki Deo, James P. Flynn, James Regan, Charles R. Crain +23 more

Monoclonal antibody treatment drives rapid culture conversion in SARS-CoV-2 infection

Cell Reports Medicine(2022)10.1016/j.xcrm.2022.100678

N/A

0DataRank · unranked

20 citations

Kara W Chew, Manish C. Choudhary, Rinki Deo, James Regan, James P. Flynn +19 more

Predictors of SARS-CoV-2 RNA From Nasopharyngeal Swabs and Concordance With Other Compartments in Nonhospitalized Adults With Mild to Moderate COVID-19

Open Forum Infectious Diseases(2022)10.1093/ofid/ofac618

N/A

0DataRank · unranked

14 citations

Jonathan Z. Li, Joseph J. Eron, Evgenia Aga, Eric S. Daar, David A. Wohl +29 more

Monoclonal antibody treatment drives rapid culture conversion in SARS-CoV-2 infection

medRxiv(2021)10.1101/2021.12.25.21268211

N/A

0DataRank · unranked

6 citations

Kara W Chew, Manish C. Choudhary, Rinki Deo, James Regan, James P. Flynn +20 more

Response to Drs de Grooth and Parienti

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae053

N/A

0DataRank · unranked

1 citations

Kara W Chew, Joseph J. Eron, Davey M. Smith, Judith S. Currier, Michael D. Hughes +1 more

ACTIV trials: Lessons learned in trial design in the setting of an emergent pandemic

Journal of Clinical and Translational Science(2024)10.1017/cts.2024.1

N/A

0DataRank · unranked

1 citations

Kevin J. Anstrom, Christina E. Barkauskas, Samuel M. Brown, Eric S. Daar, William A. Fischer +16 more

Safety, Efficacy, and Pharmacokinetics of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies BMS-986414 (C135-LS) and BMS-986413 (C144-LS) Administered Subcutaneously in Non-Hospitalized Persons with COVID-19 in a Phase 2 Trial.

Pathogens and Immunity(2024)10.20411/pai.v9i1.660

N/A

0DataRank · unranked

0 citations

Kara W Chew, Mark J Giganti, Ying Mu, Courtney V. Fletcher, Judith S. Currier +12 more

Mortality and Associated Risk Factors Among People Living With HIV With Kaposi Sarcoma: A5263/AMC066 and A5264/AMC067

JAIDS Journal of Acquired Immune Deficiency Syndromes(2024)10.1097/qai.0000000000003484

N/A

0DataRank · unranked

0 citations

Carlee Moser, Minhee Kang, Triin Umbleja, Michael D. Hughes, Thomas Campbell +14 more

Discontinuation of tenofovir disoproxil fumarate from initial ART regimens because of renal adverse events: An analysis of data from four multi-country clinical trials

UNC Libraries(2024)10.17615/912s-cf39

N/A

0DataRank · unranked

0 citations

Justin Ritz, Mina C. Hosseinipour, A AIDS Clinical Trials Group A, Michael D. Hughes, Mitch Matoga +1 more

Safety, Efficacy, and Pharmacokinetics of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies BMS-986414 (C135-LS) and BMS-986413 (C144-LS) Administered Subcutaneously in Non-Hospitalized Persons with COVID-19 in a Phase 2 Trial

UNC Libraries(2024)10.17615/14jx-sy24

N/A

0DataRank · unranked

0 citations

Carlee Moser, Mark J Giganti, Joseph J. Eron, Katya Corado, ACTIV- A Study Team +13 more

Viral and Symptom Rebound Following Anti–Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Therapy in a Randomized Placebo-Controlled Trial

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae501

N/A

0DataRank · unranked

0 citations

Brooke McGinley, Carlee Moser, Jonathan Z. Li, Teresa H. Evering, Justin Ritz +42 more

ACTIV trials: Lessons learned in trial design in the setting of an emergent pandemic

UNC Libraries(2024)10.17615/wtgx-4h88

N/A

0DataRank · unranked

0 citations

Mahesh Parmar, Roger Paredes, Kevin J. Anstrom, Stacey J. Adam, Seema Nayak +16 more

Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19

Nature Communications(2022)10.1038/s41467-022-32551-2

N/A

0DataRank · unranked

49 citations

Carlee Moser, Eric S. Daar, David A. Wohl, Jonathan Z. Li, Robert W. Coombs +21 more

Virological and drug-resistance outcomes for people living with HIV initiating or switching to tenofovir, lamivudine, and dolutegravir in six PEPFAR-supported countries: a prospective cohort study

The Lancet HIV(2025)10.1016/s2352-3018(25)00162-6

N/A

0DataRank · unranked

3 citations

Caitlyn McCarthy, Carole L. Wallis, Cissy Kityo, Michael D. Hughes, Catherine Godfrey +44 more

The Choice of Viral Load End Point in Early Phase Trials of COVID-19 Treatments Aiming to Reduce 28-Day Hospitalization and/or Death

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf282

N/A

0DataRank · unranked

4 citations

Eric Chun‐Pu Chu, Thomas A. Murray, Carolyn T. Bramante, Carlee Moser, Naomi Givens +17 more

Implementation of a seamless phase 2/3 study design in the setting of an emergent infectious disease pandemic: Lessons learned from the ACTIV-2 platform COVID-19 treatment trial

Contemporary Clinical Trials(2025)10.1016/j.cct.2025.107887

N/A

0DataRank · unranked

1 citations

Kara W Chew, Carlee Moser, Joseph J. Eron, Mauricio Pinilla, Jonathan Z. Li +8 more

Preventing Multidrug-Resistant Tuberculosis: The Dawn of a New Era

Clinical Infectious Diseases(2025)10.1093/cid/ciaf426

N/A

0DataRank · unranked

1 citations

Susan Swindells, Amita Gupta, N. Sarita Shah, Michael D. Hughes, Soyeon Kim +5 more

Rapid Elimination of Culturable SARS-CoV-2 With Intramuscular or Intravenous Administration of Antiviral Monoclonal Antibody Therapy

Open Forum Infectious Diseases(2025)10.1093/ofid/ofaf542

N/A

0DataRank · unranked

1 citations

Manish C. Choudhary, Owen T. Glover, Rachel Bender Ignacio, Julie Boucau, Kara W Chew +21 more

Predictive Markers for Sustained Viral Suppression on Dual Broadly Neutralizing Antibodies During Antiretroviral Treatment Interruption in Children

JAIDS Journal of Acquired Immune Deficiency Syndromes(2025)10.1097/qai.0000000000003663

N/A

0DataRank · unranked

1 citations

Bryan S Nelson, Gbolahan Ajibola, Terence Mohammed, Comfort Maphorisa, Corretah Boleo +13 more

Association Between Anterior Nasal and Plasma SARS-CoV-2 RNA Levels and Hospitalization or Death in Nonhospitalized Adults With Mild-to-Moderate COVID-19

UNC Libraries(2025)10.17615/jgjx-bf38

Top 100%

0DataRank

Top 100%0 citations

ACTIV- A Study Team, William A. Fischer, Jonathan Z. Li, Kara W Chew, Arzhang Cyrus Javan +12 more

Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection

UNC Libraries(2025)10.17615/m8r8-hh40

N/A

0DataRank · unranked

0 citations

Judith S. Currier, Kara W Chew, Carlee Moser, Manish C. Choudhary, Michael D. Hughes +9 more

One Week of Oral Camostat Versus Placebo in Nonhospitalized Adults With Mild-to-Moderate Coronavirus Disease 2019: A Randomized Controlled Phase 2 Trial

UNC Libraries(2025)10.17615/zdax-rk30

N/A

0DataRank · unranked

0 citations

Atasi Jana, Eric S. Daar, Arzhang Cyrus Javan, Carlee Moser, Judith S. Currier +16 more

Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19

UNC Libraries(2025)10.17615/ryrv-wq75

N/A

0DataRank · unranked

0 citations

Yan Li, Jonathan Z. Li, Rachel Bender Ignacio, Kara W Chew, Bharat Mocherla +23 more

Evaluating Viral Load Sampling Schemes and Swabbing Methods for Optimal Surrogacy

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf443

N/A

0DataRank · unranked

0 citations

Eric Chun‐Pu Chu, Thomas A. Murray, Carolyn T. Bramante, Carlee Moser, Naomi Givens +17 more

Changes in HIV-1 Subtypes B and C Genital Tract RNA in Women and Men After Initiation of Antiretroviral Therapy

UNC Libraries(2020)10.17615/73qw-z994

N/A

0DataRank · unranked

0 citations

Joan Dragavon, Yajing Bao, Robert W. Coombs, Thomas Campbell, Mina C. Hosseinipour +11 more

Brief Report: Long-Term Clinical, Immunologic, and Virologic Outcomes Among Early-Treated Children With HIV in Botswana: A Nonrandomized Controlled Clinical Trial

JAIDS Journal of Acquired Immune Deficiency Syndromes(2023)10.1097/qai.0000000000003147

N/A

0DataRank · unranked

9 citations

Kenneth Maswabi, Michael D. Hughes, Kara Bennett, Molly Pretorius-Holme, Edmund V. Capparelli +12 more

HIV-1 Protease Inhibitors and Clinical Malaria: a Secondary Analysis of the AIDS Clinical Trials Group A5208 Study

UNC Libraries(2020)10.17615/mnva-rq21

N/A

0DataRank · unranked

0 citations

Kimberly A. Porter, Frederick K. Sawe, Judith S. Currier, Abraham Siika, Charles Poole +14 more

Renal events among women treated with tenofovir/emtricitabine in combination with either lopinavir/ritonavir or nevirapine

UNC Libraries(2020)10.17615/zs64-qr43

N/A

0DataRank · unranked

0 citations

Yu Zheng, Shahin Lockman, Albert Mwafongo, Wadzanai Samaneka, Evelyn Hogg +6 more

Michael D. Hughes

Indexed papers

Top data-sharing exemplar

Papers